New Addition in Antibodies

β-catenin is a key downstream effector in the Wnt signaling pathway. It is implicated in two major biological processes in vertebrates: early embryonic development and tumorigenesis. CK1 phosphorylates β-catenin at Ser45. This phosphorylation event primes β-catenin for subsequent phosphorylation by GSK-3β. GSK-3β destabilizes β-catenin by phosphorylating it at Ser33, Ser37, and Thr41. Mutations at these sites result in the stabilization of β-catenin protein levels and have been found in many tumor cell lines.

The chondroitin sulfate proteoglycan NG2 is a type I membrane protein expressed by subpopulations of glia including oligodendroglial precursor cells and a variety of tumor cells. NG2 is involved in promoting both proliferation and motility. The extracellular domain of NG2 sequesters growth factors and binds to both growth factor receptors and extracellular matrix ligands such as fibronectin, collagens and laminin. The cytoplasmic domain is involved in activating Rac, Cdc42, and p130 Cas. PKCα phosphorylates NG2 at Thr2256, triggering the redistribution of NG2 from apical microprocesses to lamellipodia accompanied by enhanced cell motility. ERK phosphorylates NG2 at Thr2314, stimulating cell proliferation.

We, BTL Biotechno Labs Pvt. Ltd., a channel partner of PhsphoSolutions in India offer their newly introduced antibodies that detect β-catenin & endogenous levels of total NG2/CSPG4 protein and can be used in several scientific applications, including Western Blot, Immunohistochemistry, Immunocytochemistry, Flow Cytometry and Immunoprecipitation. These antibodies target proteins in Human, Mouse & Rat.
For more details, please follow the below link:
https://biotechnolabs.com/
https://lnkd.in/dvKtucpT
Anti-beta Catenin Antibody (phosphosolutions.com)
Anti-NG2/CSPG4 Antibody (phosphosolutions.com)
PhosphoSolutions
Kristin Nixon
Amy Archuleta